Rosalie Liccardo Pacula — Publications
-
The Association Between State Cannabis Policies and Cannabis Use Among Adults and Youth, United States, 2002-2019
2025
-
OPTIC R Repository and Tutorial for Creating Policy Wheel Data Visualizations
2025
-
Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
2024
-
The Cannabis Policy Scale: A New Research and Surveillance Tool for U.S. States
2024
-
The Impact of Medicaid Institutions for Mental Disease Exclusion Waivers on the Availability of Substance Abuse Treatment Services and the Varying Effect by Ownership Type
2024
-
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
2024
-
America's Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
2023
-
The Ecosystem Approach to Opioid Policy
2023
-
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process
2023
-
How Much Can You Trust the Results of This Health Policy Evaluation: A Pragmatic Guide for State Policymakers
2023
-
Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: An Observational Study
2023
-
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
2023
-
Martin Y. Iguchi (1955-2021)
2023
-
Understanding the Rise in Overdose Deaths Involving Opioids and Non-Opioid Prescription Drugs in the United States
2023
-
Cannabis Legalization and Cannabis-Involved Pregnancy Hospitalizations in Colorado
2022
-
Comparison of Hospital Claims and Poison Center Data to Evaluate Health Impact of Opioids, Cannabis and Synthetic Cannabinoids
2022
-
The Effect of State Policies on Rates of High-Risk Prescribing of an Initial Opioid Analgesic
2022
-
Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder
2022
-
Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010–2018
2022
-
APCDs Can Provide Important Insights for Surveilling the Opioid Epidemic, With Caveats
2021
-
Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond
2021
-
Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado
2021
-
Claims-based Measures of Prescription Opioid Utilization: A Practical Guide for Researchers
2021
-
Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion
2021
-
The Evolving Consequences of OxyContin Reformulation on Drug Overdoses
2021
-
Mental Health Conditions and Substance Use Disorders Among Youth Subsequently Diagnosed With Opioid Use Disorder or Opioid Poisoning
2021
-
Moving Beyond the Classic Difference-In-Differences Model: A Simulation Study Comparing Statistical Methods for Estimating Effectiveness of State-Level Policies
2021
-
Trends in Personal and Family Member Opioid Prescriptions Prior to a Diagnosis of an Opioid-Related Problem Among Adolescents and Young Adults
2021
-
How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D
2020
-
Pitfalls and Potholes: Data Issues to Consider When Analyzing State Opioid Policies, September 14, 2020
2020
-
State Approaches to Tackling the Opioid Crisis Through the Health Care System
2020
-
The State of the Science in Opioid Policy Research
2020
-
Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
2019
-
Early Evidence of the Impact of Cannabis Legalization on Cannabis Use, Cannabis Use Disorder, and the Use of Other Substances: Findings from State Policy Evaluations
2019
-
The Synthetic Opioid Surge in the United States: Insights from Mortality and Seizure Data
2019
-
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
2019
-
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?
2018
-
Marijuana Buyers in the United States, 2010–2014
2018
-
Medical Marijuana Laws and Adolescent Marijuana Use in the United States: A Systematic Review and Meta-Analysis
2018
-
A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid Use Disorders Among Medicaid Enrollees
2018
-
Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids
2018
-
A Supply-Side Perspective on the Opioid Crisis
2018
-
Advancing Knowledge on Cannabis Policy Using Evidence from North America
2017
-
Association of State Recreational Marijuana Laws with Adolescent Marijuana Use
2017
-
Did the Dependent Coverage Expansion Increase Risky Substance Use Among Young Adults?
2017
-
Early Impacts of Marijuana Legalization: An Evaluation of Prices in Colorado and Washington
2017
-
Funding Considerations in the Fight Against the Opioid Epidemic: What the Science Tells Us
2017
-
Medical Marijuana and Marijuana Legalization
2017
-
Regulating Medical Marijuana Markets: Insights from Scientific Evaluations of State Experiments
2017
-
Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids
2017
-
Understanding and Learning from the Diversification of Cannabis Supply Laws
2017
-
In the Weeds: A Baseline View of Cannabis Use Among Legalizing States and Their Neighbours
2016
-
Opioid Analgesic and Benzodiazepine Prescribing Among Medicaid-enrollees with Opioid Use Disorders: The Influence of Provider Communities
2016
-
Physician Capacity to Treat Opioid Use Disorder with Buprenorphine-Assisted Treatment
2016
-
Preventing, Identifying, and Treating Prescription Drug Misuse Among Active-Duty Service Members
2016
-
A Systematic Review of the Prevention and Treatment of Prescription Drug Misuse
2016
-
Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil Is in the Details
2015
-
Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions
2015
-
Growth in Buprenorphine Waivers for Physicians Increased Potential Access to Opioid Agonist Treatment, 2002-11
2015
-
The Marijuana Legalization Debate: Insights for Vermont
2015
-
Medical Marijuana Laws and Adolescent Marijuana Use in the USA from 1991 to 2014: Results from Annual, Repeated Cross-Sectional Surveys
2015
-
More Choice in Health Insurance Marketplaces May Reduce the Value of the Subsidies Available to Low-Income Enrollees
2015
-
Options and Issues Regarding Marijuana Legalization
2015
-
Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013
2015
-
Policies to Support a Better Treatment for Heroin and Prescription Opioid Abuse: Unlike Methadone, Buprenorphine Can Be Taken at Home, but Greater Access is Key
2015
-
Supply of Buprenorphine Waivered Physicians: The Influence of State Policies
2015
-
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties
2015
-
Cannabis Use and Antisocial Behavior Among Youth
2014
-
Decomposing Racial Disparities in Prison and Drug Treatment Commitments for Criminal Offenders in California
2014
-
Developing Public Health Regulations for Marijuana: Lessons from Alcohol and Tobacco
2014
-
The Effects of Medical Marijuana Laws on Potency
2014
-
How Big Is the U.S. Market for Illegal Drugs?
2014
-
Marijuana Liberalization Policies: Why We Can't Learn Much from Policy Still in Motion
2014
-
Natural Experiments in a Complex and Dynamic Environment: The Need for a Measured Assessment of the Evidence
2014
-
What America's Users Spend on Illegal Drugs: 2000–2010
2014
-
Why Changes in Price Matter When Thinking About Marijuana Policy: A Review of the Literature on the Elasticity of Demand
2014
-
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States
2014
-
Before the Grand Opening: Measuring Washington State's Marijuana Market in the Last Year Before Legalized Commercial Sales
2013
-
Developing Public Health Regulations for Legal Marijuana
2013
-
Design Considerations for Legalizing Cannabis: Lessons Inspired by Analysis of California's Proposition 19
2012
-
Epidemiological Model for Examining Marijuana Use Over the Life Course
2012
-
Measuring IPR infringements in the internal market: Development of a new approach to estimating the impact of infringements on sales
2012
-
A Search-Theoretic Model of the Retail Market for Illicit Drugs
2012
-
The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View
2012
-
Addiction Research Centres and the Nurturing of Creativity: RAND's Drug Policy Research Center
2011
-
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
2011
-
Bringing Perspective to Illicit Markets: Estimating the Size of the U.S. Marijuana Market
2011
-
Heterogeneity in the Composition of Marijuana Seized in California
2011
-
Invisible Wounds, Visible Savings? Using Microsimulation to Estimate the Costs and Savings Associated with Providing Evidence-Based Treatment for PTSD and Depression to Veterans of Operation Enduring Freedom and Operation Iraqi Freedom
2011
-
Substance Use and Recessions: What Can Be Learned from Economic Analyses of Alcohol?
2011
-
What Is the Impact of Using Evidence-Based Treatments for Posttraumatic Stress Disorder and Depression in Veterans?
2011
-
Altered State? Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets
2010
-
An Assessment of the Scientific Support Underlying the FY2011 Budget Priorities of the Office of National Drug Control Policy
2010
-
Examining the Impact of Marijuana Legalization on Harms Associated with Marijuana Use
2010
-
Examining the Impact of Marijuana Legalization on Marijuana Consumption: Insights from the Economics Literature
2010
-
How Might Marijuana Legalization in California Affect Public Budgets and Marijuana Consumption?
2010
-
Marijuana Use and High School Dropout: The Influence of Unobservables
2010
-
-
Risks and Prices: The Role of User Sanctions in Marijuana Markets
2010
-
Tackling problem drug use
2010
-
Assessing Changes in Global Drug Problems, 1998-2007: Main Report
2009
-
The Costs of Methamphetamine Use: A National Estimate
2009
-
Do Citizens Know Whether Their State Has Decriminalized Marijuana? Assessing the Perceptual Component of Deterrence Theory
2009
-
The Economic Cost of Methamphetamine Use in the United States, 2005
2009
-
Estimating the size of the global drug market: A demand-side approach: Report 2
2009
-
Issues in estimating the economic cost of drug abuse in consuming nations: Report 3
2009
-
Legalizing Marijuana: Issues to Consider Before Reforming California State Law
2009
-
The Incremental Inpatient Costs Associated with Marijuana Comorbidity
2008
-
Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery
2008
-
Marijuana Use and High School Dropout: The Influence of Unobservables
2008
-
What Research Tells Us About the Reasonableness of the Current Priorities of National Drug Control
2008
-
Risks and Prices: The Role of User Sanctions in Marijuana Markets
2007
-
College Students' Use of Cocaine
2006
-
Is the Drug Court Model Exportable? The Cost-Effectiveness of a Driving-Under-The-Influence Court
2006
-
Marijuana Markets: Inferences from Reports by the Household Population
2006
-
Racial Differences in Marijuana-Users' Risk of Arrest in the United States
2006
-
Alcohol and Marijuana Use Among College Students: Economic Complements or Substitutes?
2004
-
Does Marijuana Use Impair Human Capital Formation?
2004
-
Marijuana and Crime: Is There a Connection Beyond Prohibition?
2004
-
Marijuana Decriminalization: What Does it Mean in the United States?
2004
-
What We Can--And Cannot--Expect from School-Based Drug Prevention
2004
-
Cannabis Use and Dependence: Public Health and Public Policy
2003
-
Does Marijuana Use Impair Human Capital Formation?
2003
-
How State Medical Marijuana Laws Vary: A Comprehensive Review
2003
-
The Relationship Between Cigarette Use and Other Tobacco Products: Results from the 2000 National Youth Tobacco Survey
2003
-
School-Based Drug Prevention: What Kind of Drug Use Does It Prevent?
2002
-
State Medical Marijuana Laws: Understanding the Laws and Their Limitations
2002
-
What Are the True Benefits of School-Based Drug Prevention Programs?
2002
-
Does the Sunset of Mental Health Parity Really Matter?
2001
-
Economics of Youth Drug Use, Addiction and Gateway Effects
2001
-
The Effects of Macro-Level Interventions on Addictive Behavior
2001
-
The Impact of Prices and Control Policies on Cigarette Smoking Among College Students
2001
-
-
Are People With Mental Illness Getting the Help They Need? New Findings About Parity Laws, Insurance Coverage, and Access to Care
2000
-
Economics and Antihealth Behavior: The Economic Analysis of Substance Use and Abuse
2000
-
Mental Health Parity and Employer-Sponsored Health Insurance in 1999-2000
2000
-
Mental Health Parity and Employer-Sponsored Health Insurance in 1999-2000
2000
-
Mental Health Parity Legislation: Much Ado About Nothing?
2000
-
State Mental Health Parity Laws: Cause Or Consequence Of Differences In Use?
2000
-
Labor Force Participation by Persons with Mental Illness
1999
-
Sex and Race Differences in Young People's Responsiveness to Price and Tobacco Control Policies
1999
-
Economic Modelling of the Gateway Effect
1997
